Why the study?
Cited2 has been implicated in heart development, but little is known about how it affects cardiac stem cell aging.
Does Cited2 knockdown in young cardiac stem cells affect proliferation, apoptosis, and cell cycle progression similarly to aging?
Does Cited2 knockdown in young cardiac stem cells affect proliferation, apoptosis, and cell cycle progression similarly to aging?
Cited2 plays a crucial role in regulating cell cycle progression and balancing proliferation and apoptosis in cardiac stem cells during aging, offering potential insights for cell-based heart repair therapies.
Cautions against Cited2-targeted CSC therapies in patients; leaves open its validation in human cardiac regeneration.
BACKGROUND: Cardiac stem cells (CSCs) exhibit age-dependent characteristics. Cited2 has been implicated in the regulation of heart development; however, there is little known about how Cited2 affects CSC aging. RESULTS: Cited2 mRNA and protein level was downregulated in aging heart tissue and CSCs. Old (O)-CSCs showed decreased differentiation and proliferation capacities as compared to Young (Y)-CSCs, the decrease in cell proliferation, increase in apoptosis, and cell cycle arrest in G0/G1 phase in CSCs are mediated by knocdown CITED2expression in (Y)-CSCs. CONCLUSIONS: Cited2 plays an important role in cell cycle progression and in maintaining the balance between CSC proliferation and apoptosis in the process of aging without influencing cell fate decisions. These findings have important implications for cell-based therapies for heart repair.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: